Human CD Antigens

Total Page:16

File Type:pdf, Size:1020Kb

Human CD Antigens Human CD antigens Molec. Molec. Molec. Molec. Antigen Alternate names Expression Function Ligand/receptor Antigen Alternate names Expression Function Ligand/receptor Antigen Alternate names Expression Function Ligand/receptor Antigen Alternate names Expression Function Ligand/receptor mass mass mass mass CD1a T6, Leu-6, R4, HTA1 49 kDa Cortical thymocytes, Langerhans cells, DCs Antigen presentation with β-2-microglobin CD1-restricted TCR CD66b CD67, CGM6, NCA-95, 95–100 Granulocytes Adhesion, neutrophil activation CD66c CD158g KIR2DS5 – NK and T cell subsets Activation of NK cell cytolytic activity, MHC class I– – CD269 BCMA, TNFRSF13B 20 kDa Mature B cells (membrane and perinuclear) B cell survival and proliferation CD256, CD257 CEACAM8 kDa specific NK receptor CD270 TNFRSF14, tumor 30 kDa Broad, Bhi cells Viral entry, signal transduction CD258, CD272, HSV-1, CD1b R1, T6 45 kDa Cortical thymocytes, Langerhans cells, DCs Antigen presentation with β-2-microglobin CD1-restricted TCR CD66c NCA, CEACAM6 90 kDa Neutrophils, colon carcinoma Adhesion CD62E, CD66a, CD66b, CD158h KIR2DS1 50 kDa NK and T cell subsets Activation of NK cell cytolytic activity, MHC class I– HLA-C necrosis factor receptor HSV-2 CD1c BDCA-1, R7, T6, M241 43 kDa Cortical thymocytes, Langerhans cells, DCs, B Antigen presentation with β-2-microglobin CD1-restricted TCR CD66c, CD66e specific NK receptor superfamily, member cell subsets 14 (herpes virus entry CD66d CGM1, CEACAM3 35 kDa Granulocytes Putative role in cell adhesion and signaling – CD158i KIR2DS4 35, 58 NK and T cell subsets Activation of NK cell cytolytic activity, MHC class I– HLA-C mediator), TR2, ATAR, CD1d R3 49 kDa Intestinal epithelial cells, B cell subsets, Antigen presentation with β-2-microglobin CD1-restricted TCR kDa specific NK receptor HVEA, HVEM, LIGHTR low monocytes , DCs CD66e CEA, CEACAM5 180–200 Colon epithelial cells, colon cancer Adhesion CD66a, CD66c, CD66e CD158j KIR2DS2 50 kDa NK and T cell subsets Activation of NK cell cytolytic activity, MHC class I– HLA-C CD271 NGFR, p75(NTR) 45 kDa Neurons (Schwann cells, growing neurites), bone Tumor suppressor; cell survival and death NGF, BDNF, NT-3, NT-4 kDa CD1e R4 28 kDa DCs Antigen presentation with β-2-microglobin – specific NK receptor marrow mesenchymal cells CD66f PSG, Sp-1 54–72 Pregnancy-specific glycoprotein, placental Immune regulation, protection of fetus from maternal – CD2 T11, LFA-2, SRBC-R 50 kDa Thymocytes, T cells, NK cells Adhesion, T cell activation CD58 CD158k KIR3DL2 70 kDa NK and T cell subsets Inhibition of NK cell cytolytic activity, MHC class I– – CD272 BTLA 33 kDa Lymphocytes, macrophages, progenitor B and Inhibitory response CD270 kDa syncytiotrophoblasts, fetal liver immune system specific NK receptor T cells, mature BM DCs CD2R T11-3 50 kDa Tact cells Activation-dependent form of CD2 – CD68 Macrosialin, GP110 110 kDa Intracellularly in monocytes, macrophages, Scavenger receptor, antigen processing, phagocytosis Oxidized LDL CD158z KIR3DL3 NK and T cell subsets Inhibition of NK cell cytolytic activity, MHC class I– – CD273 B7DC, PD-L2, 25 kDa DC subsets, monocytes, macrophages Co-stimulation or suppression of T cell proliferation CD279 CD3ε T3 20 kDa T cells, thymocyte subsets With TCR, TCR surface expression/signal transduction – neutrophils, basophils, large lymphocytes, mast specific NK receptor PDCD1L2 cells, DCs, myeloid progenitors, liver CD4 T4, Leu3a 55 kDa Thymocyte subsets, T cell subsets, monocytes, MHC class II co-receptor, HIV receptor, MHC class II, HIV CD159a NKG2A 43 kDa T cell subsets, NK cells With CD94, NK cell receptor HLA-E CD274 B7-H1, PD-L1 33 kDa Leukocytes, broad Co-stimulation of lymphocytes CD279 macrophages T cell differentiation/activation CD69 Activation inducer 28, 32 Tact, Bact, and NKact cells; granulocytesact, resting Signal transduction – marker (AIM), very early kDa BM memory T cells, thymocytes, Langerhan DCs CD159c NKG2C 40 kDa NK cells With MHC class I HLA-E molecules, forms heterodimer HLA-E CD275 B7-H2, ICOSL, B7-RP1, 60 kDa B cells, DCs, monocytes Co-stimulation, cytokine production CD278 CD5 T1, Tp67, Leu1, Ly-1 67 kDa Thymocytes, T cells, B cell subsets, B cell TCR or BCR signaling, T and B cell interaction CD72 activation (VEA) with CD94 GL50 chronic lymphocytic leukemia act act CD160 BY55 27 kDa NK and T cell subsets Co-stimulation HLA-C CD70 Ki-24, CD27L, TNFSF7 50, 70, B and T cells T and B cell co-stimulation CD27 CD276 B7-H3 40–45 In vitro–cultured DCs and monocytes, Tact cells, Co-stimulation, T cell activation – CD6 T12 100–130 Thymocytes, T cells, B cell subsets T cell differentiation/co-stimulation CD166 90, 160 CD161 NKR-P1A 40 kDa NK cell–mediated cytotoxicity Lectin-like transcript 1 kDa mammary tissue kDa kDa T cell subsets (TH17, CD8 subsets, γδ, CD3 thymocytes), NK cells CD277 BT3.1, butyrophilin SF3 56 kDa T, B, and NK cells; monocytes, DCs, endothelial T cell activation – CD7 Leu9, gp40 40 kDa Hematopoietic progenitors, thymocytes, T cells, T cell co-stimulation K12 in epithelial cells CD71 Transferrin receptor 95 kDa Proliferating cells, reticulocytes, erythroid Iron uptake Transferrin A1, BTF5 cells, CD34+ cells, tumor cell lines, CD14+ cells NK cells (TFR), T9 precursors CD162 PSGL-1 120 kDa Monocytes, neutrophils, granulocytes, Adhesion, rolling CD62P, CD62E, CD62L peripheral T cells, Blow cells, and a subset of CD278 ICOS, AILIM 55–60 Tact and Th2 cells T cell co-stimulation CD275 CD8a T8, Leu-2, Ly-2 32–34 Thymocyte subsets, T cell subsets, NK cells MHC class I co-receptor, receptor for some mutated MHC class I + CD72 Lyb-2 42 kDa B cells, follicular DCs B cell proliferation CD5, CD100 CD34 hematopoietic progenitor cells (HPCs) in kDa kDa HIV-1, T cell differentiation/activation bone marrow CD73 NT5E, Ecto-5'- 69 kDa B cell subsets, Treg subsets, epithelial cells Ecto-5´-nucleotidase, nucleoside uptake, AMP CD279 PD1, SLEB2 55 kDa Tact and Bact cells Autoimmune disease and peripheral tolerance, CD273, CD274 CD8b Lyt-3 30–32 Thymocyte subsets, T cell subsets MHC class I co-receptor, receptor for some mutated MHC class I nucleotidase T cell co-stimulation, lymphocyte adhesion CD163 Hemoglobin scavenger 130 kDa Monocytes, macrophages Clearance of hemoglobin Hemoglobin checkpoint in tumors kDa HIV-1, T cell differentiation/activation receptor, macrophage CD74 Ii, invariant chain, 33, 35, B cells, macrophages, monocytes, Langerhans MHC class II traffic and function, binding to MIF, MIF marker CD280 ENDO180, UPARAP 180 kDa Chondrocytes, fibroblasts, endothelial cells, Collagen matrix remodeling and endocytic recycling Collagen, mannose, CD9 p24, MRP-1, DRAP-27 22–27 Pre-B cells, eosinophils, basophils, platelets, Cellular adhesion and migration PSG17, TGF-α HLA class II 41, 43 cells, DCs, Tact cells maturation of follicular B cells act macrophages fucose on glycans kDa T cells, neurons, glial cells in the peripheral histocompatibility kDa CD164 MGC-24, MUC24 80 kDa Hematopoietic progenitors, cell–stromal cell Putative role in intracellular adhesion – nervous system antigen γ chain, HLA- interaction CD281 TLR1 90 kDa Low levels in peripheral blood mononuclear Innate immunity with TLR2 Lipoprotein, lipopeptide cells, monocytes, possibly DCs CD10 CALLA, NEP, gp100 100 kDa B cell precursors, T cell precursors, neutrophils, Zinc-binding metalloproteinase, B cell development DR antigens-associated invariant chain CD165 AD2, gp37 42 kDa Mesothelial cells, T-cell acute lymphoblastic Putative role in intracellular adhesion – acute lymphoblastic leukemias leukemia (T-ALL) cells, epithelial cells, CD282 TLR2 90 kDa Monocytes, neutrophils, upregulated in Response to bacterial lipoproteins, innate immunity Lipoproteins and glycans, CD75 Lactosamines 67, 85 B cell subsets, epithelial cells Lactosamines – fibroblasts, platelets macrophages pathogen-associated CD11a LFA-1, integrin L 180 kDa Lymphocytes, granulocytes, monocytes, CD11a/CD18 receptor for ICAM-1, -2, and -3; CD50, CD54, CD102 kDa molecular patterns macrophages intercellular adhesion; T cell co-stimulation CD166 ALCAM 105 kDa Neurons, monocytes, epithelial cells, fibroblasts, Adhesion CD6 CD75s Sialylated CD75 – B cell subsets, T cell subsets -2,6-sialylated lactosamines (previously CDw75 and – Tact cells CD283 TLR3 100 kDa Monocyte-derived DCs (may be intracellular) Innate immunity dsRNA CD11b Mac-1, integrin M 170 kDa Myeloid cells, NK cells iC3 adhesion CD54, CD102, iC3b, α CDw76) fibrinogen, CD23 CD167a Discoidin domain 120 kDa Epithelial cells, myoblasts Tyrosine kinase, adhesion to collagen Collagen CD284 TLR4 100 kDa Peripheral blood mononuclear cells (weak in Innate immunity, association with MD2 and CD14 LPS CD77 Gb3, Pk blood group Germinal center B cells, Burkitt’s lymphomashigh, Apoptosis Shiga toxin, verotoxin 1 receptor family-1 (DDR1) monocytes, immature DCs, and neutrophils) CD11c p150, 95, CR4, integrin 150 kDa DCs, macrophages, monocytes, granulocytes, iC3 adhesion CD54, iC3b, fibrinogen, follicular lymphomaslow X, LeuM5 NK cells, T and B cell subsets, leukemia cells CD23 CD168 Hyaluronan-mediated 84–88 Monocytes, T cell subsets, thymocyte subsets, Adhesion, tumor migration, metastasis – CD285 TLR5 98 kDa DCs, monocytes, epithelial cell subsets Innate recognition to bacteria Flagellin CD79a Ig, MB-1 33, 45 Myeloid subsets Component of BCR, BCR surface expression, and signal – motility receptor kDa intracellularly in breast cancer cells CD13 Aminopeptidase N, APN, 150–170 Monocytes, granulocytes, some macrophages, Zinc-binding metalloproteinase, antigen processing, Coronavirus
Recommended publications
  • Versican V2 Assembles the Extracellular Matrix Surrounding the Nodes of Ranvier in the CNS
    The Journal of Neuroscience, June 17, 2009 • 29(24):7731–7742 • 7731 Cellular/Molecular Versican V2 Assembles the Extracellular Matrix Surrounding the Nodes of Ranvier in the CNS María T. Dours-Zimmermann,1 Konrad Maurer,2 Uwe Rauch,3 Wilhelm Stoffel,4 Reinhard Fa¨ssler,5 and Dieter R. Zimmermann1 Institutes of 1Surgical Pathology and 2Anesthesiology, University Hospital Zurich, CH-8091 Zurich, Switzerland, 3Vascular Wall Biology, Department of Experimental Medical Science, University of Lund, S-221 00 Lund, Sweden, 4Center for Biochemistry, Medical Faculty, University of Cologne, D-50931 Cologne, Germany, and 5Department of Molecular Medicine, Max Planck Institute of Biochemistry, D-82152 Martinsried, Germany The CNS-restricted versican splice-variant V2 is a large chondroitin sulfate proteoglycan incorporated in the extracellular matrix sur- rounding myelinated fibers and particularly accumulating at nodes of Ranvier. In vitro, it is a potent inhibitor of axonal growth and therefore considered to participate in the reduction of structural plasticity connected to myelination. To study the role of versican V2 during postnatal development, we designed a novel isoform-specific gene inactivation approach circumventing early embryonic lethality of the complete knock-out and preventing compensation by the remaining versican splice variants. These mice are viable and fertile; however, they display major molecular alterations at the nodes of Ranvier. While the clustering of nodal sodium channels and paranodal structures appear in versican V2-deficient mice unaffected, the formation of the extracellular matrix surrounding the nodes is largely impaired. The conjoint loss of tenascin-R and phosphacan from the perinodal matrix provide strong evidence that versican V2, possibly controlled by a nodal receptor, organizes the extracellular matrix assembly in vivo.
    [Show full text]
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • Role of the Chondroitin Sulfate Proteoglycan, Neurocan, in Inhibition of Sensory Neurite Regeneration Madison Klump University of Kentucky, [email protected]
    University of Kentucky UKnowledge Lewis Honors College Capstone Collection Lewis Honors College 2016 Role of the Chondroitin Sulfate Proteoglycan, Neurocan, in Inhibition of Sensory Neurite Regeneration Madison Klump University of Kentucky, [email protected] Umang Khandpur University of Kentucky, [email protected] Chris Calulot University of Kentucky, [email protected] Adrian Centers University of Kentucky, [email protected] Diane M. Snow University of Kentucky Right click to open a feedback form in a new tab to let us know how this document benefits oy u. Follow this and additional works at: https://uknowledge.uky.edu/honprog Part of the Molecular and Cellular Neuroscience Commons, and the Other Neuroscience and Neurobiology Commons Recommended Citation Klump, Madison; Khandpur, Umang; Calulot, Chris; Centers, Adrian; and Snow, Diane M., "Role of the Chondroitin Sulfate Proteoglycan, Neurocan, in Inhibition of Sensory Neurite Regeneration" (2016). Lewis Honors College Capstone Collection. 18. https://uknowledge.uky.edu/honprog/18 This Article is brought to you for free and open access by the Lewis Honors College at UKnowledge. It has been accepted for inclusion in Lewis Honors College Capstone Collection by an authorized administrator of UKnowledge. For more information, please contact [email protected]. Research article Role of the Chondroitin Sulfate Proteoglycan, Neurocan, in Inhibition of Sensory Neurite Regeneration M. Klump1, C.M. Calulot1, A.P Centers1, U. Khandpur1, and D. M. Snow1 The University of Kentucky, Spinal Cord and Brain Injury Research Center1, Lexington, KY 40536 Abbreviated Title: Role of Neurocan in Inhibition of Sensory Neurite Regeneration Pages: 13 Figures: 5 *Author to whom correspondence should be addressed: Diane M.
    [Show full text]
  • And MMP-Mediated Cell–Matrix Interactions in the Tumor Microenvironment
    International Journal of Molecular Sciences Review Hold on or Cut? Integrin- and MMP-Mediated Cell–Matrix Interactions in the Tumor Microenvironment Stephan Niland and Johannes A. Eble * Institute of Physiological Chemistry and Pathobiochemistry, University of Münster, 48149 Münster, Germany; [email protected] * Correspondence: [email protected] Abstract: The tumor microenvironment (TME) has become the focus of interest in cancer research and treatment. It includes the extracellular matrix (ECM) and ECM-modifying enzymes that are secreted by cancer and neighboring cells. The ECM serves both to anchor the tumor cells embedded in it and as a means of communication between the various cellular and non-cellular components of the TME. The cells of the TME modify their surrounding cancer-characteristic ECM. This in turn provides feedback to them via cellular receptors, thereby regulating, together with cytokines and exosomes, differentiation processes as well as tumor progression and spread. Matrix remodeling is accomplished by altering the repertoire of ECM components and by biophysical changes in stiffness and tension caused by ECM-crosslinking and ECM-degrading enzymes, in particular matrix metalloproteinases (MMPs). These can degrade ECM barriers or, by partial proteolysis, release soluble ECM fragments called matrikines, which influence cells inside and outside the TME. This review examines the changes in the ECM of the TME and the interaction between cells and the ECM, with a particular focus on MMPs. Keywords: tumor microenvironment; extracellular matrix; integrins; matrix metalloproteinases; matrikines Citation: Niland, S.; Eble, J.A. Hold on or Cut? Integrin- and MMP-Mediated Cell–Matrix 1. Introduction Interactions in the Tumor Microenvironment.
    [Show full text]
  • Pan-KIR2DL NK-Receptor Antibodies and Their Use in Diagnostik and Therapy
    (19) TZZ _ T (11) EP 2 287 195 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 23.02.2011 Bulletin 2011/08 C07K 16/28 (2006.01) G01N 33/52 (2006.01) (21) Application number: 10178924.6 (22) Date of filing: 01.07.2005 (84) Designated Contracting States: • Romagne, François AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 13600 La Ciotat (FR) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Wagtmann, Peter, Andreas, Nicolai, Reumert SK TR 2960 Rungsted Kyst (DK) • Svendsen, Ivan (30) Priority: 06.01.2005 DK 200500025 2765 Smorum (DK) 01.07.2004 PCT/DK2004/000470 • Zahn, Stefan 01.07.2004 PCT/IB2004/002464 2750 Ballerup (DK) • Svensson, Anders (62) Document number(s) of the earlier application(s) in 21746 Malmö (DK) accordance with Art. 76 EPC: • Thorolfsson, Matthias 05758642.2 / 1 791 868 2920 Charlottenlund (DK) • Berg Padkaer, Soren (71) Applicants: 3500 Vaerlose (DK) • Novo Nordisk A/S • Kjaergaard, Kristian 2880 Bagsvaerd (DK) 2750 Ballerup (DK) • Innate Pharma • Spee, Pieter 13009 Marseille (FR) 3450 Allerod (DK) • Universita di Genova • Wilken, Michael 16132 Genova (IT) 3390 Hundested (DK) (72) Inventors: (74) Representative: Gallois, Valérie et al • Moretta, Alessandro Cabinet BECKER & ASSOCIES 16133 Genova (IT) 25, rue Louis Le Grand • Della Chiesa, Mariella 75002 Paris (FR) 16132 Genova (IT) • Andre, Pascale Remarks: 13006 Marseille (FR) This application was filed on 23-09-2010 as a • Gauthier, Laurent divisional application to the application mentioned 13008 Marseille (FR) under INID code 62.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Cd1b Tetramers Bind T Cell Receptors to Identify a Mycobacterial
    Published August 1, 2011 Brief Definitive Report CD1b tetramers bind T cell receptors to identify a mycobacterial glycolipid- reactive T cell repertoire in humans Anne G. Kasmar,1 Ildiko van Rhijn,1,2 Tan-Yun Cheng,1 Marie Turner,3 Chetan Seshadri,1 Andre Schiefner,4 Ravi C. Kalathur,4 John W. Annand,1 Annemieke de Jong,1 John Shires,5 Luis Leon,1 Michael Brenner,1 Ian A. Wilson,4 John D. Altman,5 and D. Branch Moody1 1Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115 2Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3508 TD Utrecht, Netherlands 3Tuberculosis Treatment Unit, Lemuel Shattuck Hospital, Jamaica Plain, MA 02130 4Department of Molecular Biology and Skaggs Institute for Chemical Biology, the Scripps Research Institute, La Jolla, CA 92037 Downloaded from 5Emory Vaccine Center, Atlanta, GA 30329 Microbial lipids activate T cells by binding directly to CD1 and T cell receptors (TCRs) or by indirect effects on antigen-presenting cells involving induction of lipid autoantigens, CD1 transcription, or cytokine release. To distinguish among direct and indirect mechanisms, we developed fluorescent human CD1b tetramers and measured T cell staining. CD1b tetramer staining of T cells requires glucose monomycolate (GMM) antigens, is specific for TCR jem.rupress.org structure, and is blocked by a recombinant clonotypic TCR comprised of TRAV17 and TRBV4-1, proving that CD1b–glycolipid complexes bind the TCR. GMM-loaded tetramers brightly stain a small subpopulation of blood-derived cells from humans infected with Mycobacterium tuberculosis, providing direct detection of a CD1b-reactive T cell reper- toire.
    [Show full text]
  • Cellular and Molecular Signatures in the Disease Tissue of Early
    Cellular and Molecular Signatures in the Disease Tissue of Early Rheumatoid Arthritis Stratify Clinical Response to csDMARD-Therapy and Predict Radiographic Progression Frances Humby1,* Myles Lewis1,* Nandhini Ramamoorthi2, Jason Hackney3, Michael Barnes1, Michele Bombardieri1, Francesca Setiadi2, Stephen Kelly1, Fabiola Bene1, Maria di Cicco1, Sudeh Riahi1, Vidalba Rocher-Ros1, Nora Ng1, Ilias Lazorou1, Rebecca E. Hands1, Desiree van der Heijde4, Robert Landewé5, Annette van der Helm-van Mil4, Alberto Cauli6, Iain B. McInnes7, Christopher D. Buckley8, Ernest Choy9, Peter Taylor10, Michael J. Townsend2 & Costantino Pitzalis1 1Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Departments of 2Biomarker Discovery OMNI, 3Bioinformatics and Computational Biology, Genentech Research and Early Development, South San Francisco, California 94080 USA 4Department of Rheumatology, Leiden University Medical Center, The Netherlands 5Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands 6Rheumatology Unit, Department of Medical Sciences, Policlinico of the University of Cagliari, Cagliari, Italy 7Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, UK 8Rheumatology Research Group, Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham B15 2WB, UK 9Institute of
    [Show full text]
  • Flow Reagents Single Color Antibodies CD Chart
    CD CHART CD N° Alternative Name CD N° Alternative Name CD N° Alternative Name Beckman Coulter Clone Beckman Coulter Clone Beckman Coulter Clone T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells CD1a T6, R4, HTA1 Act p n n p n n S l CD99 MIC2 gene product, E2 p p p CD223 LAG-3 (Lymphocyte activation gene 3) Act n Act p n CD1b R1 Act p n n p n n S CD99R restricted CD99 p p CD224 GGT (γ-glutamyl transferase) p p p p p p CD1c R7, M241 Act S n n p n n S l CD100 SEMA4D (semaphorin 4D) p Low p p p n n CD225 Leu13, interferon induced transmembrane protein 1 (IFITM1). p p p p p CD1d R3 Act S n n Low n n S Intest CD101 V7, P126 Act n p n p n n p CD226 DNAM-1, PTA-1 Act n Act Act Act n p n CD1e R2 n n n n S CD102 ICAM-2 (intercellular adhesion molecule-2) p p n p Folli p CD227 MUC1, mucin 1, episialin, PUM, PEM, EMA, DF3, H23 Act p CD2 T11; Tp50; sheep red blood cell (SRBC) receptor; LFA-2 p S n p n n l CD103 HML-1 (human mucosal lymphocytes antigen 1), integrin aE chain S n n n n n n n l CD228 Melanotransferrin (MT), p97 p p CD3 T3, CD3 complex p n n n n n n n n n l CD104 integrin b4 chain; TSP-1180 n n n n n n n p p CD229 Ly9, T-lymphocyte surface antigen p p n p n
    [Show full text]
  • Expression of Inflammation-Related Intercellular Adhesion Molecules in Cardiomyocytes in Vitro and Modulation by Pro-Inflammatory Agents
    in vivo 30: 213-218 (2016) Expression of Inflammation-related Intercellular Adhesion Molecules in Cardiomyocytes In Vitro and Modulation by Pro-inflammatory Agents IBRAHIM EL-BATTRAWY1,2,3, EROL TÜLÜMEN2,3, SIEGFRIED LANG1,2,3, IBRAHIM AKIN2,3, MICHAEL BEHNES2,3, XIABO ZHOU1,2,3,4, MARTIN MAVANY2, PETER BUGERT5, KAREN BIEBACK5, MARTIN BORGGREFE2,3 and ELIF ELMAS2,3 1Division of Experimental Cardiology and 2First Department of Medicine, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany; 3German Center for Cardiovascular Research, Partner Site, Heidelberg-Mannheim, Mannheim, Germany; 4Institute of Cardiovascular Research, Sichuan Medical University, Luzhou, Sichuan, P.R. China; 5Institute for Transfusion Medicine and Immunology, Mannheim, Germany Abstract. Background: Cell-surface adhesion molecules not result in increased levels of CD31 (p>0.10). The pro- regulate multiple intercellular and intracellular processes and inflammatory agents LPS and thrombin had no effect on the play important roles in inflammation by facilitating leukocyte expression of MADCAM1 and F11R. Conclusion: endothelial transmigration. Whether cardiomyocytes express Inflammation-related cell-adhesion molecules CD31, surface-adhesion molecules related to inflammation and the MADCAM1 and F11R were shown to be expressed on the effect of pro-inflammatory mediators remain unknown. surface of human cardiomyocytes in an in vitro model. Materials and Methods: In the present study, the expression Incubation with LPS or thrombin resulted in increased of different cell-adhesion molecules (CD11a, CD11b, CD31, expression of CD31, however, it did not modify the expression CD62P, CD162, F11 receptor and mucosal vascular addressin of the cell adhesion molecules MADCAM1 and F11R. cell adhesion molecule 1 (MADCAM1)) and the effect of pro- inflammatory mediators were investigated in an in vitro model Coronary artery disease remains the leading cause of mortality of human cardiomyocytes.
    [Show full text]
  • Supplementary Material DNA Methylation in Inflammatory Pathways Modifies the Association Between BMI and Adult-Onset Non- Atopic
    Supplementary Material DNA Methylation in Inflammatory Pathways Modifies the Association between BMI and Adult-Onset Non- Atopic Asthma Ayoung Jeong 1,2, Medea Imboden 1,2, Akram Ghantous 3, Alexei Novoloaca 3, Anne-Elie Carsin 4,5,6, Manolis Kogevinas 4,5,6, Christian Schindler 1,2, Gianfranco Lovison 7, Zdenko Herceg 3, Cyrille Cuenin 3, Roel Vermeulen 8, Deborah Jarvis 9, André F. S. Amaral 9, Florian Kronenberg 10, Paolo Vineis 11,12 and Nicole Probst-Hensch 1,2,* 1 Swiss Tropical and Public Health Institute, 4051 Basel, Switzerland; [email protected] (A.J.); [email protected] (M.I.); [email protected] (C.S.) 2 Department of Public Health, University of Basel, 4001 Basel, Switzerland 3 International Agency for Research on Cancer, 69372 Lyon, France; [email protected] (A.G.); [email protected] (A.N.); [email protected] (Z.H.); [email protected] (C.C.) 4 ISGlobal, Barcelona Institute for Global Health, 08003 Barcelona, Spain; [email protected] (A.-E.C.); [email protected] (M.K.) 5 Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain 6 CIBER Epidemiología y Salud Pública (CIBERESP), 08005 Barcelona, Spain 7 Department of Economics, Business and Statistics, University of Palermo, 90128 Palermo, Italy; [email protected] 8 Environmental Epidemiology Division, Utrecht University, Institute for Risk Assessment Sciences, 3584CM Utrecht, Netherlands; [email protected] 9 Population Health and Occupational Disease, National Heart and Lung Institute, Imperial College, SW3 6LR London, UK; [email protected] (D.J.); [email protected] (A.F.S.A.) 10 Division of Genetic Epidemiology, Medical University of Innsbruck, 6020 Innsbruck, Austria; [email protected] 11 MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, W2 1PG London, UK; [email protected] 12 Italian Institute for Genomic Medicine (IIGM), 10126 Turin, Italy * Correspondence: [email protected]; Tel.: +41-61-284-8378 Int.
    [Show full text]
  • Endothelial Barrier Function and Leukocyte Transmigration in Atherosclerosis
    biomedicines Review Endothelial Barrier Function and Leukocyte Transmigration in Atherosclerosis Thijs J. Sluiter 1,2 , Jaap D. van Buul 3 , Stephan Huveneers 4, Paul H. A. Quax 1,2 and Margreet R. de Vries 1,2,* 1 Department of Vascular Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands; [email protected] (T.J.S.); [email protected] (P.H.A.Q.) 2 Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands 3 Sanquin Research and Landsteiner Laboratory, Leeuwenhoek Centre for Advanced Microscopy, Swammerdam Institute for Life Sciences, University of Amsterdam, 1066 CX Amsterdam, The Netherlands; [email protected] 4 Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, Location AMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands; [email protected] * Correspondence: [email protected]; Tel.: +31-(71)-526-5147 Abstract: The vascular endothelium is a highly specialized barrier that controls passage of fluids and migration of cells from the lumen into the vessel wall. Endothelial cells assist leukocytes to extravasate and despite the variety in the specific mechanisms utilized by different leukocytes to cross different vascular beds, there is a general principle of capture, rolling, slow rolling, arrest, crawling, and ultimately diapedesis via a paracellular or transcellular route. In atherosclerosis, the barrier function of the endothelium is impaired leading to uncontrolled leukocyte extravasation and Citation: Sluiter, T.J.; van Buul, J.D.; vascular leakage. This is also observed in the neovessels that grow into the atherosclerotic plaque Huveneers, S.; Quax, P.H.A.; de Vries, leading to intraplaque hemorrhage and plaque destabilization.
    [Show full text]